Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001853:Bone Marrow / Q000187:drug effects; D003298:Coombs Test; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use*; D005455:Fluorescent Antibody Technique; D006400:Hematocrit; D007111:Immunity, Cellular; D007668:Kidney / Q000032:analysis; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects; D015122:Mercaptopurine / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice; D009000:Monocytes; D005719:gamma-Globulins / Q000032:analysis
D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D005719:gamma-Globulins; D003520:Cyclophosphamide; D015122:Mercaptopurine